Diagnoptics News

What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

Breakthrough publication: diabetes screening with AGE Reader

Groningen, the Netherlands. November 22, 2017.

Recently a new breakthrough publication about the AGE Reader was published. It concerns an analysis of 79.248 subjects of the LifeLines study, a longitudinal cohort study with 167.000 participants. The aim of this study was to investigate whether the AGE Reader would improve the FINDRISC model in detecting undiagnosed diabetes. In addition a simplified model with only the AGE Reader, BMI and age was tested.

In this paper the authors conclude that the AGE Reader measurement significantly improves the performance of the FINDRISC score in detecting diabetes. Furthermore, the simplified model (only AGE Reader, BMI and age) was shown to have a similar performance for diabetes detection compared to the full FINDRISC.

Please click here for the full-text version of this paper.

What are the key messages of this validation paper for the AGE Reader? 

  1. This study provides strong clinical validation for a broad application of the AGE Reader as a non-invasive screening tool to detect diabetes.
  2. This study provides a clinical validation in a huge study group of almost 80.000 subjects.
  3. This study is performed in general population and not in a specific patient group.

Share this link on:

Latest news items

  1. Breakthrough publication: diabetes screening with AGE Reader 24 November 2017
  2. AGE Reader product updates at EASD 2017 – Lisbon 13 September 2017
  3. MSP bodmann GmbH appointed as new distributor in Germany 29 June 2017
  4. New key publication: large scale study in metabolic syndrome 13 June 2017
  5. Diagnoptics appoints DiosPharma as the new Korean distributor 7 November 2016
  6. Visit Diagnoptics at the EASD congress 2016 in Munich 26 August 2016
  7. Selista appointed as new Japanese distributor for the AGE Reader mu 19 May 2016
  8. Diagnoptics bei dem DDG Kongress in Berlin 16 April 2016
  9. Diagnoptics receives Chinese market approval for AGE Reader SU 12 February 2016
  10. New patent granted to Diagnoptics in Japan and EU. 7 January 2016
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.a